Announcements Trials

Browse Landscape

Clinical Trials

1 trials

Recent Start date Enrollment

Has announcements × Breast Diseases × taxane × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasm Metastasis 1 Breast Neoplasms 1 Breast Diseases 1

Interventions

trastuzumab deruxtecan 1 taxane 1 ribociclib 1 pertuzumab 1 Trastuzumab 1 Fulvestrant 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04784715 2026-02-20

Trastuzumab Deruxtecan (T-DXd) With or Without Pertuzumab Versus Taxane, Trastuzumab and Pertuzumab in HER2-positive Metastatic Breast Cancer (DESTINY-Breast09)

AstraZeneca

Phase 3 Active not recruiting

1,157 enrolled 2 FDA

Breast Diseases, Breast Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡